—Mkt Cap: —P/E: —
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing i…
Industry Peers
Health Care Technologyloading…
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value395.52M USD
Revenue (TTM)389.42M USD
Gross Profit345.62M USD
Net Income (TTM)48.58M USD
Revenue/Share2.630 USD
Last Price—
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees808
CountryUS
SectorHealth Care
IndustryHealth Care Technology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)29.47
PEG2.88
EV/EBITDA7.48
EV/Revenue1.02
P/S1.38
P/B2.08
EPS (TTM)0.20
EPS (Forward)0.12
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin82.56%
Oper. Margin-27.21%
EBITDA Margin13.58%
Profit Margin11.60%
ROE18.94%
ROA14.18%
Growth
Revenue Growth-33.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF74.00M USD
CapEx (TTM)1.03M USD
FCF Margin15.62%
FCF Yield—
Net Debt-142.18M USD
Net Debt/EBITDA-2.69
Balance Sheet
Debt/Equity0.07
Current Ratio5.39
Quick Ratio4.62
Book Value/Sh1.732 USD
Cash/Share1.073 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split3235:10000
Split DateApr 2, 2008
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)6.500 USD
Target Range5.000 USD – 8.000 USD
# Analysts6
Ownership
Shares Out.148.95M
Float117.99M
Insiders1.94%
Institutions77.04%
Short Interest
Short Ratio4.9d
Short % Float7.09%
Short % Out.5.63%
Shares Short8.39M
Short (prev mo.)7.67M
Technical
SMA 503.762 USD
SMA 2005.813 USD
Beta1.46
S&P 52W Chg28.31%
Avg Vol (30d)—
Avg Vol (10d)1.51M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—